“Tierra Biosciences Secures $11M Funding for Cutting-Edge AI-Driven Protein Innovation”

Gettyimages 1255451837
Simply put, Tierra is enabling customers to order proteins online that can make anything from antibodies to growth factor for a food product. Its reagents are combined with the customer’s protein sequences, and put into a robotic platform to create the proteins. We profiled Tierra Biosciences in 2018 after it rebranded from Synvitrobio and raised $2.6 million in new financing. Prior to joining the company, Nemzek was chief commercial officer at Synthego Corp. where he led the commercial expansion and growth of its CRISPR genome engineering business. The round had participation from new and existing investors, including Prosus Ventures, In-Q-Tel (IQT), Hillspire, Freeflow Ventures, Creative Ventures and Social Capital.